Research interests
Leads the CEPHEA EFS active clinical trial recruiting research participants or patients[8]
Anita W Asgar
Affiliated with Northwestern Medical Group
Current relationship
Affiliated with Northwestern Medical Group
Current relationship
Anita W. Asgar is a Northwestern University Feinberg School of Medicine professor whose work centers on interventional and structural heart care, including structural heart interventions and moderate secondary mitral regurgitation. She leads recruiting studies and registries evaluating transcatheter aortic, mitral, and tricuspid therapies. Canadian and born and raised in Newfoundland, she earned her MD from Memorial University of Newfoundland in 1999, completed internal medicine residency there in 2002, and pursued cardiology training at Dalhousie University. Her subsequent training included fellowships at Dalhousie, the Institut de Cardiologie de Montreal, Royal Brompton Hospital, and in cardiac magnetic resonance imaging. In 2010, she began Quebec’s first transcatheter mitral valve leaflet repair program. Public 2025 and 2026 accounts reported Northwestern leadership roles, while exact tenure dates remain unclear.
Canadian, born and raised in Newfoundland
Reported a consulting or related activity relationship with Abbott Structural Heart Solutions for calendar year 2025
Reported a consulting or related activity relationship with Curry Rockefeller Group, LLC for calendar year 2025
Reported a consulting or related activity relationship with Medtronic, Inc. for calendar year 2025
Each topic is linked to its supporting source in Sources.
Training includes Fellowship at Montreal University, Fellowship at Dalhousie University, Internal Medicine residency at Memorial University, completed in 2002, and Cardiology training at Dalhousie University beginning in 2002, plus 6 more records.
Explore education and trainingAs of 2026
As of 2026
As of 2025
As of 2024
2010
As of 2010
As of 2009
As of 2007
As of 2005
As of 2002
As of 2002
As of 1999
Leads the CEPHEA EFS active clinical trial recruiting research participants or patients[8]
Leads the Cephea MVD Registry active clinical trial or registry recruiting research participants or patients[8]
Leads the ENVISION active clinical trial recruiting research participants or patients[8]
Leads the Journey active clinical trial recruiting research participants or patients[8]
Leads the PARADIGM active clinical trial recruiting research participants or patients[8]
Leads the PATHFINDER active clinical trial recruiting research participants or patients[8]
Leads the TRICURE EFS active clinical trial recruiting research participants or patients[8]
Structural heart interventions and moderate secondary mitral regurgitation[9]